BRODSZKI, Nicholas, Ashley FRAZER-ABEL, Anete S. GRUMACH, Anete S. KIRSCHFINK, Jiří LITZMAN, Elena PEREZ, Mikko R. J. SEPPANEN, Kathleen E. SULLIVAN and Stephen JOLLES. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management. Journal of Clinical Immunology. New York: Springer, 2020, vol. 40, No 4, p. 576-591. ISSN 0271-9142. Available from: https://dx.doi.org/10.1007/s10875-020-00754-1.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management
Authors BRODSZKI, Nicholas (752 Sweden), Ashley FRAZER-ABEL (840 United States of America), Anete S. GRUMACH (76 Brazil), Anete S. KIRSCHFINK (276 Germany), Jiří LITZMAN (203 Czech Republic, belonging to the institution), Elena PEREZ (840 United States of America), Mikko R. J. SEPPANEN (246 Finland), Kathleen E. SULLIVAN (840 United States of America) and Stephen JOLLES (826 United Kingdom of Great Britain and Northern Ireland, guarantor).
Edition Journal of Clinical Immunology, New York, Springer, 2020, 0271-9142.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 8.317
RIV identification code RIV/00216224:14110/20:00116025
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s10875-020-00754-1
UT WoS 000516182000001
Keywords in English Complement; complement deficiencies; classical pathway; alternative pathway; mannan-binding lectin
Tags 14110114, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 17/7/2020 09:41.
Abstract
This guideline aims to describe the complement system and the functions of the constituent pathways, with particular focus on primary immunodeficiencies (PIDs) and their diagnosis and management. The complement system is a crucial part of the innate immune system, with multiple membrane-bound and soluble components. There are three distinct enzymatic cascade pathways within the complement system, the classical, alternative and lectin pathways, which converge with the cleavage of central C3. Complement deficiencies account for similar to 5% of PIDs. The clinical consequences of inherited defects in the complement system are protean and include increased susceptibility to infection, autoimmune diseases (e.g., systemic lupus erythematosus), age-related macular degeneration, renal disorders (e.g., atypical hemolytic uremic syndrome) and angioedema. Modern complement analysis allows an in-depth insight into the functional and molecular basis of nearly all complement deficiencies. However, therapeutic options remain relatively limited for the majority of complement deficiencies with the exception of hereditary angioedema and inhibition of an overactivated complement system in regulation defects. Current management strategies for complement disorders associated with infection include education, family testing, vaccinations, antibiotics and emergency planning.
PrintDisplayed: 28/7/2024 06:38